Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11172736rdf:typepubmed:Citationlld:pubmed
pubmed-article:11172736lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:11172736lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:11172736lifeskim:mentionsumls-concept:C0021760lld:lifeskim
pubmed-article:11172736lifeskim:mentionsumls-concept:C0029418lld:lifeskim
pubmed-article:11172736lifeskim:mentionsumls-concept:C0029463lld:lifeskim
pubmed-article:11172736lifeskim:mentionsumls-concept:C0014563lld:lifeskim
pubmed-article:11172736lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:11172736lifeskim:mentionsumls-concept:C1155125lld:lifeskim
pubmed-article:11172736lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:11172736pubmed:issue3lld:pubmed
pubmed-article:11172736pubmed:dateCreated2001-2-22lld:pubmed
pubmed-article:11172736pubmed:abstractTextEpinephrine increased gene- and protein-expression of interleukin-6 (IL-6) and interleukin-11 (IL-11), which are capable of stimulating the development of osteoclasts from their hematopoietic precursors, in human osteoblast (SaM-1) and human osteosarcoma (SaOS-2, HOS, and MG-63) cell lines. An increase in IL-6 and IL-11 synthesis in response to epinephrine appeared to be a common feature in osteoblastic cells, but the magnitude of expression was different in these cell lines. In HOS cells treated with epinephrine, increases of IL-6 and IL-11 synthesis were inhibited by timolol (a beta-blocker), H-89 (N-[2-((p-bromocinnamyl)amino)ethyl]-5-isoquinolinesulfonamide; an inhibitor of protein kinase A (PKA)) and SB203580 [4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole; an inhibitor of p38 mitogen-activated protein kinase (MAPK)], but not by phentolamine (an alpha-blocker), calphostin C [an inhibitor of protein kinase C (PKC)], or PD98059 (2'-amino-3'-methoxyflavone; an inhibitor of classic MAPK), suggesting a common pathway mediated by beta-adrenergic receptors in the PKA and p38 systems involved in the signal transduction of IL-6 and IL-11. Furthermore, expression of both genes was inhibited by curcumin [an inhibitor of activating protein-1 (AP-1) activation], but not by pyrrolidine dithiocarbamate (PDTC) [an inhibitor of nuclear factor (NF)-kappaB]. The pharmacological study suggested that coinduction of the two genes in response to epinephrine occurred via activation of AP-1. The findings of the present study suggest that coinduction of IL-6 and IL-11 in response to epinephrine probably occurs via the PKA and p38 MAPK systems, leading to the transcriptional activation of AP-1 in human osteoblastic cells.lld:pubmed
pubmed-article:11172736pubmed:languageenglld:pubmed
pubmed-article:11172736pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:citationSubsetIMlld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11172736pubmed:statusMEDLINElld:pubmed
pubmed-article:11172736pubmed:monthFeblld:pubmed
pubmed-article:11172736pubmed:issn0006-2952lld:pubmed
pubmed-article:11172736pubmed:authorpubmed-author:KondoAAlld:pubmed
pubmed-article:11172736pubmed:authorpubmed-author:MogiMMlld:pubmed
pubmed-article:11172736pubmed:authorpubmed-author:KoshiharaYYlld:pubmed
pubmed-article:11172736pubmed:authorpubmed-author:TogariAAlld:pubmed
pubmed-article:11172736pubmed:issnTypePrintlld:pubmed
pubmed-article:11172736pubmed:day1lld:pubmed
pubmed-article:11172736pubmed:volume61lld:pubmed
pubmed-article:11172736pubmed:ownerNLMlld:pubmed
pubmed-article:11172736pubmed:authorsCompleteYlld:pubmed
pubmed-article:11172736pubmed:pagination319-26lld:pubmed
pubmed-article:11172736pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:meshHeadingpubmed-meshheading:11172736...lld:pubmed
pubmed-article:11172736pubmed:year2001lld:pubmed
pubmed-article:11172736pubmed:articleTitleSignal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells.lld:pubmed
pubmed-article:11172736pubmed:affiliationDepartment of Pharmacology, School of Dentistry, Aichi-Gakuin University, 464-8650, Nagoya, Japan.lld:pubmed
pubmed-article:11172736pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11172736pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11172736lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11172736lld:pubmed